why choose us

Course: Optimizing Frontline Treatment Decisions in CLL: Evolving Evidence and Real-World Applications

CME Credits: 0.50

Released: 2025-12-19

Advances in our understanding of chronic lymphocytic leukemia (CLL) have led to the identification of prognostic and predictive biomarkers that inform treatment decisions, while novel targeted therapies have significantly reshaped guideline recommendations. Despite this progress, notable gaps remain in the clinical management of CLL, particularly for oncologists serving rural and underserved communities. Consequently, there is a critical need for education on best practices in CLL care. This online, on-demand CME/CE activity—part of the series Keeping Up With the Evolving Landscape of CLL: Practical Solutions for Reducing Disparities in Rural and Underserved Communities—will review advances in frontline CLL treatment, including the safety and efficacy of available regimens and the latest clinical trial data. Expert faculty will also discuss the role of biomarkers in therapy selection and the value of a multidisciplinary approach to patient management in rural and underserved settings. The content for this enduring activity was recorded on December 12, 2025.


Upon completion of this activity, participants should be better able to:


View Full Course